[Non-Hodgkin lymphomas. New histological, cytological and prognostic correlations (author's transl)].
In a homogenous series of 58 patients with non-Hodgkin lymphoma, clinical, histological, cytological and prognostic correlations were investigated by the same pathologists and clinicians, using Kiel's classification. The survival rate at 3 years was 78% for stage I and II lymphomas and 37% for stage III and IV lymphomas. Nodular forms had a better prognosis. There was good correlation between prognosis and Kiel's classification of cytological forms. The survival rate was 81% in low grade malignancy lymphomas and 28% in high grade malignancy lymphomas with immunoblasts, pure centroblasts and lymphoblasts. The poor survival rate of patients with immunoblastic sarcoma was due to a variety of the disease with totally undifferentiated, highly proliferative cells.
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D008224:Lymphoma, Follicular / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis
Hématosarcomes non hodgkiniens. Nouvelles corrélations histologiques, cytologiques et pronostiques.